Effects of endocrine therapy on the primary lesion in patients with prostate carcinoma as evaluated by endorectal magnetic resonance imaging

Cancer

Volumn 80, Issue 2, 1997, Pages 237-241

  Nakashima, Jun ^a   Imai, Yutaka ^a   Tachibana, Masaaki ^a   Baba, Shiro ^a   Hiramatsu, Kyoichi ^a   Murai, Masaru ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Endocrine therapy; Magnetic resonance imaging; Prostate neoplasms; Tumor volume

Indexed keywords

ANDROGEN;

ARTICLE; CANCER SIZE; CANCER STAGING; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; HISTOPATHOLOGY; HORMONAL THERAPY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CARCINOMA;

ANTINEOPLASTIC AGENTS, HORMONAL; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASMS, HORMONE-DEPENDENT; PROSTATE; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS;

EID: 0030996854     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970715)80:2<237::AID-CNCR11>3.0.CO;2-V     Document Type: Article

References (19)

1. Schanll MD, Lenkinski RE, Pollack HM, Imai Y, Kressel HY. Prostate: MR imaging with an endorectal surface coil. Radiology 1989;172:570-4.
2. Schnall MD, Imai Y, Tomaszewski J, Pollack HM, Lenkinski RE, Kressel HY. Prostate cancer: local staging with endorectal surface coil MR imaging. Radiology 1991;178:797-802.
3. Chen M, Hricak H, Kalbhen CL, Kurhanewicz J, Vigneron DB, Weiss JM, et al. Hormonal ablation of prostatic cancer: effects on prostate morphology, tumor detection, and staging by endorectal coil MR imaging. AJR Am J Roentgenol 1996;166:1157-63.
4. Bezzi M, Kressel HY, Allen KS, Schiebler ML, Altman HG, Wein AJ, et al. Prostatic carcinoma: staging with MR imaging at 1.5 T. Radiology 1988;169:339-46.
5. Sommer FG, Nghiem HV, Herfkens R, McNeal JE, Low RN. Determining the volume of peostatic carcinoma: value of MR imaging with an external array coil. AJR Am J Roentgenol 1993;161:81-6.
6. Schroder FH, Hermanek P, Denis L, Fair WR, Gospodarowicz MK, Pavone-Macaluso M. The TNM classification of prostate cancer. Prostate (Suppl) 1992;4:129-38.
7. Pinault S, Monfette G, Tetu B, Dupont A, Gagnon J, Labrie F. Transrectal ultrasound evaluation of local prostate cancer in patients treated with LHRH agonist and in combination with flutamide. Urology 1992;39:254-61.
8. Kojima M, Watanabe H, Ohe H, Miyashita H, Inaba T. Kinetic evaluation of the effect of LHRH analog on prostatic cancer using transrectal ultrasonotomography. Prostate 1987;10:11-7.
9. Resnick MI, Willard JW, Boyce WH. Transrectal ultrasonography in the evaluation of patients with prostate cancer. J Urol 1980;124:482-4.
10. Andros EA, Danesghari F, Crawford ED. Neoadjuvant hormonal therapy in stage C adenocarcinoma of the prostate. Clin Invest Med 1993;16:510-5.
11. Schulman CC, Sassine AM. Neoadjuvant hormonal deprivation before radical prostatectomy. Clin Invest Med 1993; 16:523-31.
12. Okihara K, Watanabe M, Saitoh M, Ohe H, Watanabe H. Kinetic analysis of focal hypoechoic lesion in the prostate treated by castration. Prostate 1994;24:252-6.
13. Gabrilobe JL, Levive AC, Kircshenbaum A, Droller M. Effect of a GnRH analogue (leuprolide) on benign prostatic hypertrophy. J Clin Endocrinol Metab 1987;64:1331-3.
14. Schroeder FH, Westerhof M, Bosch RJ, Kurth KH. Benign prostatic hyperplasia treated by castration or the LH-RH analogue buserelin: a report on 6 cases. Eur Urol 1986; 12:318-21.
15. Peters CA, Walsh PC. The effect of nafarelin acetate, a luteinizing hormone-releasing hormone agonist, on benign prostatic hyperplasia. N Engl J Med 1987;317:599-604.
16. Chelsky MJ, Schnall MD, Seidmon EJ, Pollack HM. Use of endorectal surface coil magnetic resonance imaging for local staging of prostate cancer. J Urol 1993;150:391-5.
17. Murphy WM, Soloway MS, Barrows GH. Pathologic changes associated with androgen deprivation therapy for prostate cancer. Cancer 1991;68:821-8.
18. Peeling WB, Griffiths GJ, Jones DR, Ryan PG, Roberts EE, Evans KT. The United Kingdom experience: clinical trials for carcinoma of the prostate monitored by ultrasound. Prog Clin Biol Res 1987;237:161-76.
19. Oesterling JE, Andrews PE, Suman VJ, Zincke H, Myers RP. Preoperative androgen deprivation therapy: artificial lowering of serum prostate specific antigen without downstaging the tumor. J Urol 1993;149:779-82.